N-palmitoylethanolamide in the treatment of neuropathic pain associated with lumbosciatica (Q39251343)

10 September 2017

title

N-palmitoylethanolamide in the treatment of neuropathic pain associated with lumbosciatica (English)

1 reference

10 September 2017

0 references

C Morera Domínguez

1 reference

10 September 2017

A Díaz Martín

1 reference

10 September 2017

F Garibo Ferrer

1 reference

10 September 2017

Ma Ibáñez Puertas

1 reference

10 September 2017

A Leal Muro

1 reference

10 September 2017

Jc Martí González

1 reference

10 September 2017

J Pombo Prieto

1 reference

10 September 2017

I Rosselló Taberna

1 reference

10 September 2017

publication date

1 March 2012

1 reference

10 September 2017

1 reference

10 September 2017

1 reference

10 September 2017

1 reference

10 September 2017

page(s)

119-124

1 reference

Sciatica: review of epidemiological studies and prevalence estimates

10 September 2017

cites work

1 reference

The updated cochrane review of bed rest for low back pain and sciatica

21 January 2018

1 reference

Diagnosis and treatment of sciatica

21 January 2018

1 reference

Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey

21 January 2018

1 reference

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

21 January 2018

1 reference

Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4).

21 January 2018

1 reference

Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment

21 January 2018

1 reference

The Oswestry Disability Index

21 January 2018

1 reference

Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance

21 January 2018

1 reference

N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation

21 January 2018

1 reference

Control of pain initiation by endogenous cannabinoids.

21 January 2018

1 reference

The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons

21 January 2018

1 reference

An Examination of the Observed Placebo Effect Associated with the Treatment of Low Back Pain – A Systematic Review

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/PMT.12.5

0 references

1 reference